Successful treatment with belantamab mafodotin in a heavily pretreated patient with multiple myeloma and liver extramedullary disease

MeSH terms

• Antibodies, Monoclonal, Humanized* / therapeutic use
• Antineoplastic Agents / therapeutic use
• Female
• Humans
• Liver Neoplasms* / drug therapy
• Liver Neoplasms* / pathology
• Male
• Middle Aged
• Multiple Myeloma* / drug therapy
• Multiple Myeloma* / pathology
• Treatment Outcome